Abstract
Understanding why some people establish and maintain effective control of HIV-1 and others do not is a priority in the effort to develop new treatments for HIV/AIDS. Using a whole-genome association strategy, we identified polymorphisms that explain nearly 15% of the variation among individuals in viral load during the asymptomatic set-point period of infection. One of these is found within an endogenous retroviral element and is associated with major histocompatibility allele human leukocyte antigen (HLA)-B*5701, whereas a second is located near the HLA-C gene. An additional analysis of the time to HIV disease progression implicated two genes, one of which encodes an RNA polymerase I subunit. These findings emphasize the importance of studying human genetic variation as a guide to combating infectious agents.
MeSH Terms
Cohort Studies
DNA-Binding Proteins/genetics
Disease Progression
Female
Genes, MHC Class I
Genome, Human
HIV Infections/genetics,immunology,therapy,virology
HIV-1/physiology
HLA-B Antigens/genetics
HLA-C Antigens/genetics
Haplotypes
Humans
Immediate-Early Proteins/genetics
Major Histocompatibility Complex/genetics
Male
Polymorphism, Single Nucleotide
RNA, Long Noncoding
RNA, Untranslated
Regression Analysis
Viral Load
Chemicals
DNA-Binding Proteins
HCP5 long noncoding RNA, human
HLA-B Antigens
HLA-B*57:01 antigen
HLA-C Antigens
Immediate-Early Proteins
POLR1H protein, human
RNA, Long Noncoding
RNA, Untranslated
RNF39 protein, human
Authors & Affiliations
27 authors, click to expand affiliations / ORCID
Fellay Jacques
Center for Population Genomics and Pharmacogenetics, Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710, USA.
Shianna Kevin V
Ge Dongliang
Colombo Sara
Ledergerber Bruno
Weale Mike
Zhang Kunlin
Gumbs Curtis
Castagna Antonella
Cossarizza Andrea
Cozzi-Lepri Alessandro
De Luca Andrea
Easterbrook Philippa
Francioli Patrick
Mallal Simon
Martinez-Picado Javier
Miro José M
Obel Niels
Smith Jason P
Wyniger Josiane
Descombes Patrick
Antonarakis Stylianos E
Letvin Norman L
McMichael Andrew J
Haynes Barton F
Telenti Amalio
Goldstein David B
References (22)
22 references, click to expand
-
Genomics meets HIV-1.
Nat Rev Microbiol. 2006 Nov;4(11):865-73
PMID: 17041633
-
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.
Nat Genet. 2006 Oct;38(10):1166-72
PMID: 16998491
-
Nef interference with HIV-1-specific CTL antiviral activity is epitope specific.
Blood. 2006 Nov 15;108(10):3414-9
PMID: 16882705
-
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14
PMID: 10694578
-
Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA.
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8955-60
PMID: 10922055
-
Cellular immune responses to HIV.
Nature. 2001 Apr 19;410(6831):980-7
PMID: 11309628
-
The influence of HLA genotype on AIDS.
Annu Rev Med. 2003;54:535-51
PMID: 12525683
-
T cell dynamics in HIV-1 infection.
Annu Rev Immunol. 2003;21:265-304
PMID: 12524385
-
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
AIDS. 2003 Dec 5;17(18):2581-91
PMID: 14685052
-
Human genes that limit AIDS.
Nat Genet. 2004 Jun;36(6):565-74
PMID: 15167933
-
Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection.
J Virol. 2004 Oct;78(19):10747-54
PMID: 15367641
-
A novel coding sequence belonging to a new multicopy gene family mapping within the human MHC class I region.
Immunogenetics. 1993;38(1):47-53
PMID: 8462994
-
The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein.
J Cell Sci. 1995 Aug;108 ( Pt 8):2811-23
PMID: 7593322
-
Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses.
AIDS. 1997 Dec;11(15):1884-6
PMID: 9412710
-
The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16.
Immunogenetics. 1999 May;49(5):404-12
PMID: 10199916
-
The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.
Immunity. 1999 Jun;10(6):661-71
PMID: 10403641
-
Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression.
J Virol. 2005 Oct;79(20):12674-80
PMID: 16188970
-
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
J Virol. 2006 Apr;80(7):3617-23
PMID: 16537629
-
Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
J Exp Med. 2006 May 15;203(5):1357-69
PMID: 16682496
-
Genome-wide associations of gene expression variation in humans.
PLoS Genet. 2005 Dec;1(6):e78
PMID: 16362079
-
Using mutual information to measure the impact of multiple genetic factors on AIDS.
J Acquir Immune Defic Syndr. 2006 Jul;42(3):347-54
PMID: 16763524
-
Principal components analysis corrects for stratification in genome-wide association studies.
Nat Genet. 2006 Aug;38(8):904-9
PMID: 16862161